Biocept, Inc. (BIOC) Social Stream

Biocept, Inc. (BIOC): $1.14

0.03 (+2.25%)

POWR Rating

Component Grades













Biocept Inc (BIOC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BIOC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-03 1 $14 $12 $13 $2.32 460.34%

Price Target Last Issued December 3, 2021

The Trend in the Analyst Price Target

Over the past 46 weeks, BIOC's average price target has gone down $7.

Over the past 35 weeks, BIOC's average upside potential has been 231.77%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-03 0 20 20 20 4.88 309.84%
2021-05-03 0 20 20 20 4.69 326.44%
2021-07-24 0 12 12 12 4.12 191.26%
2021-09-18 0 12 12 12 4.01 199.25%
2021-10-08 1 14 12 13 3.91 232.48%

BIOC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BIOC as an investment opportunity.

  • In terms of how Biocept Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than just about none of of that group.
  • BIOC has a greater upside potential (average analyst target price relative to current price) than 92.11% of Healthcare stocks.
  • In the context of Healthcare stocks, Biocept Inc's variance in analysts' estimates is lower than 89.54% of them.
  • Biocept Inc's average analyst price target is greater than 15.41% of Healthcare stocks.

Stocks similar to Biocept Inc in the Healthcare industry regarding analyst recommendations and price targets are ANPC, AKU, and FTRP.

Make investment decisions regarding BIOC using the data that counts. Try POWR Ratings for free.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4478 seconds.